Metal (Au, Pt, Pd, Ni) Bis(dithiolene) complexes as dual-action agents combating cancer and trypanosomatid infections

Hadi Hachem1, Yann Le Gal1, Olivier Jeannin1

  • 1Univ Rennes, CNRS, ISCR (Institut des Sciences Chimiques de Rennes) - UMR 6226, F-35000 Rennes, France.

PubMed

Insights

New metal bis(dithiolene) complexes show potent anticancer and anti-Trypanosoma cruzi activities. These compounds, including platinum and palladium variants, demonstrate broad-spectrum efficacy and potential as novel therapeutic agents against cancer and parasitic infections.

Area of Science:

  • Medicinal Chemistry
  • Inorganic Chemistry
  • Parasitology

Background:

  • Cancer and infectious diseases are major global health threats requiring novel broad-spectrum treatments.
  • Metal bis(dithiolene) complexes offer a promising avenue for developing new therapeutic agents due to their diverse chemical properties.

Purpose of the Study:

  • To investigate the anticancer and antitrypanosomatid (anti-Trypanosoma cruzi) activities of eight novel monoanionic metal bis(dithiolene) complexes.
  • To evaluate the selectivity and potential mechanisms of action of these complexes compared to established drugs.

Main Methods:

  • Synthesis and characterization of eight [Ph4P][M(R-thiazdt)2] complexes (M = Au, Pt, Pd, Ni; R = Et, tBu).
  • In vitro evaluation of anticancer activity against A2780 ovarian cancer cells and A2780cisR cells.
  • Assessment of antitrypanosomatid activity against Trypanosoma cruzi.
  • Determination of selectivity index (SI) using normal human dermal fibroblasts (HDF).
  • Investigation of cell death mechanisms, including reactive oxygen species (ROS) generation and apoptosis assays.

Main Results:

  • All complexes exhibited significant anticancer activity (IC50: 0.6-3.8 μM) against A2780 cells, with some overcoming cisplatin resistance.
  • [Ph4P][Pd(tBu-thiazdt)2] showed a promising selectivity index (SI=10).
  • All complexes demonstrated potent antitrypanosomatid activity (IC50: 2.6-5.8 μM), with some outperforming nifurtimox.
  • Cell death was primarily mediated by ROS generation, though apoptosis was not clearly evident.
  • Gold complexes showed lower ROS generation compared to other metals but were still superior to auranofin.

Conclusions:

  • The synthesized metal bis(dithiolene) complexes possess significant anticancer and antitrypanosomatid activities.
  • [Ph4P][Pt(tBu-thiazdt)2] and [Ph4P][Pd(tBu-thiazdt)2] show particular promise as novel therapeutic agents.
  • These complexes represent potential alternatives to current treatments for cancer and Chagas disease, warranting further investigation.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
907
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
40
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K